Picture of Vitrolife AB logo

VITR — Vitrolife AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Vitrolife: Update Of Coronavirus's Impact On Vitrolife's Sales

March 17 (Reuters) - Vitrolife AB  VITR.ST :
    * UPDATE OF CORONAVIRUS'S IMPACT ON VITROLIFE'S SALES
    * VITROLIFE ESTIMATES THAT SALES DURING Q1 WILL BE
APPROXIMATELY
IN LINE WITH LAST YEAR IN LOCAL CURRENCY AND THAT EBITDA MARGIN
WILL AMOUNT TO APPROXIMATELY 33-37 PERCENT
    * FURTHERMORE, COMPANY ASSESS THAT Q2 WILL BE SIGNIFICANTLY
NEGATIVELY IMPACTED BY VIRUS OUTBREAK
    * AND VITROLIFE EXPECTS A CONTINUOUSLY EXPANDING MARKET,
WHICH IN
MONETARY TERMS IS EXPECTED TO GROW BY 5-10 PER CENT PER YEAR FOR
FORESEEABLE FUTURE
    * IT IS DIFFICULT TO ESTIMATE HOW VIRUS OUTBREAK WILL AFFECT
DEMAND FOR IVF TREATMENTS DURING Q2 OTHER THAN THAT IT WILL
LIKELY HAVE A SIGNIFICANT NEGATIVE EFFECT

Source text for Eikon:  ID:nWkr1SG5Xx 
Further company coverage:  VITR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Vitrolife AB

See all news